X

Pharmaceutical

Sun Pharma Advanced Research Q3FY23 Earnings

(SPARC) Sun Pharma Advanced Research Company Limited conducts pharmaceutical product research and development (R&D). Financial Results: After nine consecutive quarters…

Shilpa Medicare Limited Q3FY23 Earnings

With cutting-edge technology, Shilpa Medicare is in the business of manufacturing high-quality Active Pharmaceutical Ingredients, Intermediates, Formulations, Novel Drug delivery…

Sanofi India Limited Q3FY23 Earnings Story

Sanofi India primarily deals with the Manufacture and sale of pharmaceutical products. Financial Results: The company reported a decline of…

Procter & Gamble Health Q2FY23 Earnings Story

Procter & Gamble Health Ltd. primarily deals with both manufacturing and marketing various chemicals and pharmaceuticals. Financial Results: Procter &…

NATCO Pharma Limited Q3FY23 Earnings

A pharmaceutical firm with a strong focus on research and development, NATCO Pharma Ltd creates, produces, and markets sophisticated pharmaceuticals…

Pfizer Limited Q3FY23 Earnings Story

Pfizer Ltd is primarily involved in marketing, exporting, manufacturing, and trading of pharmaceutical products. It produces goods through its in-house…

Panacea Biotec Q3FY23; 26% Fall in Revenue

Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937…

Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Transcript

Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director,…

Lupin Limited Q3FY23; 47% Growth in Profits

Lupin Limited’s revenue in Q3FY23 rose 13% to ₹ 1,97,66,301 lakhs. Consolidated Profit After Tax came at ₹ 8,34,871 lakhs…

Sun Pharmaceutical Q3FY23; 3% Growth in Profits

Sun Pharmaceutical Industries Limited’s revenue in Q3FY23 rose 14% to ₹ 112,410 millions. Consolidated Profit After Tax came at ₹…